Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sussman, H. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sussman, H. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 17, No. 3, 272-275
© Oxford University Press 2000


Selections from Current Literature

Mammography screening for breast cancer in women under 50 years

Howard R Sussman

Department of Family Medicine, Health Sciences Center L-4, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.

Sussman HR. Mammography screening for breast cancer in women under 50 years. Family Practice 2000; 17: 272–275.

This instalment of ‘Selections from current literature’ tackles an issue that is both important and controversial: mammography screening for breast cancer in women under 50 years old. The articles reviewed were chosen as the most up-to-date evidence available. As such, the information contained herein may enable the family physician to apply population-based epidemiology to an individual setting. Thus, the doctor and patient may make informed decisions about this highly personal, vitally important topic.

Antman K, Shea S. Screening mammography under age 50. J Am Med Assoc 1999; 281: 1470–1472.

In this article, the authors chronicle the history of breast cancer screening recommendations. Upon completion of the first six randomized mammography trials in 1989, the American Cancer Society, the National Cancer Institute (NCI) and various other organizations issued joint recommendations for women aged 40–75 years. Subsequent analysis, however, demonstrated negligible benefit in the 40- to 49-year-old subgroup. This was in striking . . . [Full Text of this Article]

Comment

Comment

Comment

Summary

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?